Meet us at the 2nd annual Spatial Biology for Drug Development Summit.
We’re excited to be a Program Partner for the Spatial Biology for Drug Development Summit, returning to Boston for a 2nd year, October 22-24. This year, we’ll dive into the latest in spatial omics technologies and explore cutting-edge applications in cancer, immunology, and more. Join us to exchange insights, learn about optimized data analysis techniques using machine learning, and form valuable partnerships with top spatial technology developers and researchers.
Since 2009, we’ve led the way in spatial biology, being among the first to utilize machine learning and AI for spatial analysis and establishing ourselves as the most dependable partner for your clinical program. With seventeen US patents backing our proprietary image analysis technology, Flagship partners with you to deliver customized data to meet your unique needs. Starting with assessment and determining the correct modalities, our dedicated and collaborative scientific and project management teams provide end-to-end support throughout the entire process, from pre-IND to commercialization.
- AI-powered digital pathology solutions
- Biomarker development and validation
- Spatial biology and molecular diagnostics analysis
- Clinical trial support
- CDx development
- Regulatory guidance
Schedule a meeting to learn how we can partner for your Spatial Biology and Biomarkers solutions, from developing and validating high dimensional assays to evaluating gene expression within the spatial context of a biological sample.
Tom Turi, Ph.D.
Chief Scientific Officer at Flagship Biosciences
Wednesday, October 23
11:15 AM ET
Enhancing Targeted Therapeutics with Spatial Biology
- Innovative methods in biomarker discovery utilizing spatial biology.
- Leveraging spatial biology to advance the development of antibody-drug conjugates (ADCs).
- Integrating spatial biology techniques to improve patient-specific treatment strategies.
Gene Expression Analysis Within Spatial Context
- Ability to rapidly translate your basic science discoveries into actionable clinical insights using state-of-the-art sequencing platforms from NanoString
- Combination of standard immunofluorescence techniques with digital optical barcoding technology to perform spatial, highly multiplexed, tissue profiling
- Wide range of standard and customizable gene expression panels
The Digital Pathology Advantage
- Improve ROI, accelerate trials, and minimize budget impacts
- Minimize recruitment costs and other clinical trial expenses
- Pathologist-directed image analysis using industry-standard scanning technology, including Akoya PhenoImager™ HT for multiplex fluorescent scanning.
Validated Assays for Clinical Research & Drug Development
- Customizable options optimized to your needs and validation requirements
- Ability to create multiplex assays to characterize complex cellular interactions
Driving Your Biomarker Strategy: Facts by Numbers
- View our resume and history to learn why Flagship is the premier partner for your study
- See the full list of spatial biology services that empower confident clinical decision making
- See the benefits with a fully integrated team of scientists and pathologists